Substance misuse in patients with schizophrenia: a primary care guide
- 5 May 2003
- journal article
- Published by AMPCo in Medical Journal of Australia
- Vol. 178 (S9) , S71-S75
Abstract
Smoking presents a substantial health and economic burden to people with schizophrenia. Comorbid use of other substances is common, under‐recognised, and associated with a number of serious adverse consequences, such as psychotic relapse and poorer social outcomes. All patients with schizophrenia need to be screened for substance misuse. Effective interventions involve integrated, modified pharmacological and psychosocial strategies.Keywords
This publication has 12 references indexed in Scilit:
- The pharmacotherapy of smoking cessationMedical Journal of Australia, 2002
- Motivations That Maintain Substance Use Among Individuals With Psychotic DisordersSchizophrenia Bulletin, 2002
- Substance abuse in schizophrenia: a review of the literature and a study of correlates in SwedenSchizophrenia Research, 2001
- Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in SchizophreniaAmerican Journal of Psychiatry, 2000
- Causes of the excess mortality of schizophreniaThe British Journal of Psychiatry, 2000
- Psychosocial Approaches to Dual DiagnosisSchizophrenia Bulletin, 2000
- Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomesSchizophrenia Research, 1999
- Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patientsSchizophrenia Research, 1999
- Patterns of Current and Lifetime Substance Use in SchizophreniaSchizophrenia Bulletin, 1998
- Countertransference and Attitudes in the Context of Clinical Work with Dually Diagnosed Patients1993